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pressure values nor the duration of symptoms were found to 
improve explanation of the underlying status. At 3 months, 
stroke, recurrent TIA and myocardial infarction were absent 
in patients with TIA mimics but occurred in 13 (5.2%), 20 
(8.1%) and 3 (1.2%) TIA patients, respectively.  Conclusions: 
About 1 in every 5 patients with suspected TIA had a TIA 
mimic. Paresis suggested TIA, while other clinical variables 
used in risk assessment scores after TIA were not shown to 
distinguish between the two entities. Patients with TIA mim-
ics had a better short-term prognosis. 
 Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Patients suffering from a transient ischemic attack 
(TIA) have a high risk of stroke within the first 3 months, 
ranging from 9% up to 20% at 90 days  [1–9] . The risk of 
stroke is particularly high in the first few days, underlin-
 Key Words 
 Transient ischemic attack   Mimics   Emergency medical 
services   Clinical symptoms   Outcome 
 Abstract 
 Background: There is insufficient evidence regarding which 
clinical features are best suited to distinguish between tran-
sient ischemic attack (TIA) and disorders mimicking TIA (TIA 
mimics).  Methods: We compared the frequency, clinical 
characteristics and outcome of patients with TIA and TIA 
mimics in a prospective, single-center emergency depart-
ment cohort over 2 years.  Results: Of 303 patients, 248 
(81.8%) had a TIA and 55 (18.2%) had TIA mimics. Epileptic 
seizures (26/55; 43.7%) and migraine attacks (13/55; 23.6%) 
were the most common TIA mimics. In patients presenting 
with unilateral paresis, TIA mimics were less likely than in pa-
tients without unilateral paresis [odds ratio (OR) 0.35, 95% 
confidence interval (CI) 0.17–0.68]. Memory loss (OR 9.17,
95% CI 2.89–32.50), headache (OR 3.71, 95% CI 1.07–12.78) 
and blurred vision (OR 2.48, 95% CI 0.90–6.59) increased the 
odds of TIA mimics. Once these clinical features were taken 
into account, neither aphasia, dysarthria, sensory loss, blood 
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ing the need for urgent evaluation and treatment of pa-
tients with TIA  [10] . However, there are patients with 
transient focal neurological symptoms which are not at-
tributable to a focal cerebral ischemia  [11] . Such condi-
tions may imitate a TIA and can therefore be labeled TIA 
mimics, in analogy to conditions that imitate a stroke and 
have been labeled stroke mimics  [12, 13] . The rate of TIA 
mimics ranges from 10 to 48.5%  [14–17] depending on 
the setting. Diagnostic procedures and therapeutic mea-
sures differ between patients with TIA and patients with 
TIA mimics. Therefore, it would be useful to identify 
clinical features which aid in distinguishing between the 
two entities. With these considerations in mind, we com-
pared the frequency, clinical characteristics and progno-
sis of patients with TIA and patients with TIA mimics 
presenting to an experienced stroke center.
 Methods 
 Setting and Study Objectives 
 The Basel Stroke Unit program includes a prospective registry 
and defines management pathways. In summer 2006, we de-
signed a prospective, single-center TIA study with the following 
objectives: (1) to evaluate the quality of the management of TIA 
patients in our hospital  [18] , (2) to explore which features are best 
suited to distinguish between TIA and disorders mimicking TIA 
and (3) to test whether a refinement of the age, blood pressure, 
clinical symptoms and duration of symptoms (ABCD) score may 
increase the predictability of subsequent stroke or recurrent TIA. 
 Over a period of 24 months (from 5 November 2006 to 4 No-
vember 2008), all consecutive patients admitted to the emergency 
department (EMD) with suspected TIA as assessed by the EMD 
physician were analyzed.
 Due to lack of a universally agreed definition of TIA mimics 
 [11, 14, 15] , we distinguished the two entities by adapting the cri-
teria used to distinguish stroke from stroke mimics as follows. 
Adhering to the classical definition, TIA was defined as an acute 
loss (i.e. within seconds or less) of focal cerebral or ocular func-
tion with symptoms lasting  ! 24 h of presumed ischemic origin 
 [11, 19] . All patients with an underlying nonischemic disorder 
were classified as having TIA mimics  [11] . The clinical diagnosis 
of TIA is subject to interobserver disagreement  [20, 21] . In order 
to minimize the risk of misclassification, two stroke neurologists 
blinded to the final outcome assessed case report forms and clin-
ical data by chart review and reclassified the patients as TIA or 
TIA mimics by consensus, adopting a similar approach to that 
used for distinguishing stroke from mimics  [12] . The diagnosis of 
TIA or TIA mimics was based on clinical criteria alone; the results 
of diagnostic investigations such as neuroimaging or EEG did not 
play a role in this process.
 Data were collected on a standardized case report form that 
was prospectively applied in all patients. The following variables 
were assessed: demographic variables (age, sex), body mass index, 
details of clinical symptoms, vascular risk factors based on crite-
ria used in a previous study  [22] , ABCD  [23] and age, blood pres-
sure, clinical symptoms, duration of symptoms and diabetes 
(ABCD2) scores  [15] , vital signs and findings of the ancillary in-
vestigations detailed below. We collected information on 11 clin-
ical symptoms: unilateral paresis (i.e. one-sided weakness of the 
face, arm and/or leg), unilateral sensory loss (i.e. one-sided numb-
ness or altered sensation including pins and needles in the face, 
arm and/or leg), aphasia (i.e. inability to use or understand lan-
guage, either spoken or written), dysarthria (i.e. slurred speech), 
transient monocular blindness (i.e. partial or total blindness of 
one eye), hemianopia (i.e. blindness to one side), diplopia (i.e. dou-
ble vision), vertigo (i.e. a sensation of a whirling motion, either of 
the patient or of the environment), blurred vision, memory loss 
and headache. Features present in only a few patients e.g. parapa-
resis (n = 7), tetraparesis (n = 4), march of symptoms (n = 5) and 
limb movement (n = 3), were excluded from the analysis in anal-
ogy to a recent study on stroke mimics  [12] .
 Appropriate measures of stroke prevention were initiated im-
mediately based on current guidelines  [19] . This included starting 
antithrombotic agents, statins, antihypertensive therapy and life-
style counseling, as well as specific interventions tailored to the 
underlying etiology. Antiplatelet therapy with acetylsalicylic acid 
(ASA) as the first-line agent was used in patients with TIA due to 
large-artery atherosclerosis, small-artery occlusion or of undeter-
mined etiology; clopidogrel was used in patients with contraindi-
cations for ASA or for those who were on ASA at the time of their 
index TIA. Anticoagulation with phenprocoumon was used for 
cardioembolic TIAs.
 Patients with 4 or fewer points on the ABCD score  [23] , no 
acute ischemic lesions on diffusion-weighted MRI of the brain, 
less than 50% stenosis of the large arteries and no high-risk ab-
normality on electrocardiogram (ECG) were managed as outpa-
tients, whereas patients presenting at least one of these criteria 
were hospitalized.
 At 3 months, patients were followed up clinically at outpatient 
visits by a stroke neurologist. The following outcome events were 
assessed: stroke, recurrent TIA and myocardial infarction (MI). 
Stroke was defined as an acute deficit of focal neurological func-
tion with symptoms lasting more than 24 h, resulting from an 
intracranial vascular disturbance (ischemia or hemorrhage). The 
diagnosis of MI required 2 out of the following 3 criteria: a his-
tory of prolonged chest discomfort, the development of specific 
abnormalities on a standard 12-lead ECG and specific cardiac en-
zymes elevated more than twice the upper limit of normal. All 
outcome events were adjudicated by a senior stroke neurologist.
 If patients did not accept our invitation for a clinical follow-up 
visit, their vital status was investigated. A standardized telephone 
interview was carried out in those who declined follow-up visits 
to assess any symptoms of the above-defined vascular outcome 
events. If this interview showed signs suggestive of a vascular 
event, an urgent clinical visit with further investigations was 
scheduled in order to evaluate the occurrence of an outcome 
event. 
 Statistical Analysis 
 We used descriptive statistics with absolute and relative fre-
quencies for categorical variables and median and interquartile 
range for continuous variables to study differences in the distri-
bution of patient characteristics at baseline between patients with 
TIA and TIA mimics. The p values calculated using Fisher’s exact 
test and the Mann-Whitney test, respectively, are also shown.
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 To assess whether the continuous variables considered for pre-
dictive modeling have strictly linear effects, we fitted univariate 
additive logistic regression models using penalized regression 
splines for the smoothers  [24] .
 We included 15 prespecified candidate predictors (i.e. 11 
symptoms plus age, symptom duration, diastolic and systolic 
blood pressure) in univariate linear logistic regression models, 
where the effect of variables which were present exclusively in one 
group (e.g. TIA) and were absent in the other group was evaluated 
with exact inference  [25–28] .
 The primary analysis was performed with a classical multiple 
linear logistic regression model chosen in a stepwise algorithm 
via the Akaike information criterion  [29] . Variables suffering 
from small-data problems were not included in this model, but 
were studied later in a post hoc multiple regression analysis by 
means of exact inference.
 Predictive performance of this model was evaluated with the 
Brier score  [30] and the area under the receiver operating char-
acteristic curve (AUC). A useful prediction rule should have a 
Brier score below 0.25, indicating the worst case scenario for de-
cision making. Resubstitution comparisons are likely to be too 
optimistic. Therefore, we also used bootstrap cross-validation 
with  B =  25 subsamples and applied the 0.632+ method  [31] . For 
a fair comparison model selection was performed in each boot-
strap sample.
 Analyses were performed using the R system for statistical 
computing  [32] .
 Ethics 
 The local ethics committee approved the study.
 Results 
 Study Population 
 All 303 patients admitted to the EMD with suspected 
TIA during the study enrolment period were included in 
the present analysis. All study patients had a clinical neu-
rological exam on admission; in addition, the following 
diagnostic tests were performed in some patients (num-
ber of tests; percentage in TIA patients; percentage in pa-
tients with TIA mimics). Computed tomography (CT) 
with CT angiography (n = 194; 62.9%; 69.1%), MRI, in-
cluding diffusion-weighted imaging and MR angiogra-
phy (n = 251; 81.9%; 87.3%), transthoracic echocardiogra-
phy (n = 183; 66.1%; 34.5%), transesophageal echocar-
diography (n = 22; 7.3%; 7.3%), neurosonology (n = 277; 
94.0%; 80.0%), ECG (n = 303; 100.0%; 100.0%), 24-hour 
ECG (n = 126; 45.2%; 25.5%) and EEG (n = 48; 10.9%; 
38.2%). Patient characteristics at baseline are shown in 
 table 1 .
 Fifty-five patients (18.2%) were classified as having 
TIA mimics. Epileptic seizures (43.7%) and migraine at-
tacks (23.6%) were the most common diagnoses among 
patients with TIA mimics ( table 2 ).
 Atrial fibrillation was more common in patients with 
TIA (n = 37; 14.9%) than in patients with TIA mimics
(n = 1; 1.8%; p = 0.006). Gender, body mass index and the 
frequency of other vascular risk factors were balanced be-
Table 1. P atient baseline characteristics
All patients
(n = 303)
TIA mimics
(n = 55; 18.2%)
TIA
(n = 248; 81.8%)
p value
Age, years
Males
71 (61.0–79.0)
178 (58.8)
66 (56.0–76.5)
29 (52.7)
72 (62.0–79.0)
149 (60.1)
0.0502
0.3643
Vascular risk factors 
Hypertension 211 (69.6) 36 (65.5) 175 (70.6) 0.5173
Coronary heart disease 53 (17.5) 6 (10.9) 47 (18.9) 0.1753
Current smoking 60 (19.8) 7 (12.7) 53 (21.4) 0.1903
Diabetes mellitus 48 (15.8 ) 7 (12.7) 41 (16.5) 0.5473
Hypercholesterolemia 115 (38.0 ) 19 (34.5) 96 (38.7) 0.6463
Family history of stroke 70 (23.1) 16 (29.1) 54 (21.8) 0.2883
Peripheral arterial disease 24 (7.9) 2 (3.6) 22 (8.9) 0.2723
Atrial fibrillation 38 (12.5) 1 (1.8) 37 (14.9) 0.0063
BMI1 25.3 (23.3–27.9) 25.7 (23.5–28.3) 25.2 (23.3–27.8) 0.4022
ABCD score
ABCD2 score
4.0 (3.0–5.0)
4.0 (3.0–5.0)
4.0 (3.0–5.0)
4.0 (3.0–5.0)
4.0 (3.0–5.0)
4.0 (3.0–5.0)
0.0272
0.0182
V alues represent medians (interquartile ranges) or numbers (percentages). BMI = Body mass index;
ABCD = prognostic score developed to determine stroke risk after TIA [15]. 
1 Based on 240/303 patients. 2 Mann-Whitney test. 3 Fisher’s exact test.
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tween the TIA and TIA mimic groups. ABCD (p = 0.027) 
and ABCD2 scores (p = 0.018) tended to be lower in TIA 
mimics compared with TIA patients.
 Predicting TIA Mimics versus TIA 
 All 303 patients were considered for regression analy-
sis, except for regression on blood pressure values, where 
2 patients could not be considered due to missing values.
 For age, symptom duration and diastolic and systolic 
blood pressure, no relevant nonlinear effects were detect-
ed. In the univariate linear logistic regression models ( ta-
ble 3 ), the duration of symptoms, blood pressure at ad-
mission, aphasia, dysarthria, vertigo, hemianopia, tran-
sient monocular blindness, diplopia and unilateral 
sensory loss did not show a statistically significant effect 
on the odds of TIA mimics. An increase of 5 years in age 
accounted for a decrease in the odds of TIA mimics of 
10% [odds ratio (OR) 0.90, 95% confidence interval (CI) 
0.81–1.00]. Unilateral paresis accounted for a decrease in 
the TIA mimics odds of 71% (OR 0.29, 95% CI 0.15–0.54). 
Memory loss (OR 10.80, 95% CI 3.66–36.07), blurred vi-
sion (OR 5.04, 95% CI 2.14–11.87) and headache (OR 5.86, 
95% CI 2.01–17.47) were each associated with an increase 
in the odds of TIA mimics.
 We note that transient monocular blindness (n = 15) 
and diplopia (n = 12) occurred among TIA patients but 
were absent among patients with TIA mimics. Therefore, 
the stepwise linear logistic regression model selected 4 
out of 13 variables ( table 4 ): unilateral paresis (OR 0.35, 
95% CI 0.17–0.68), headache (OR 3.71, 95% CI 1.07–12.78), 
memory loss (OR 9.17, 95% CI 2.89–32.50) and blurred 
vision (OR 2.48, 95% CI 0.90–6.59).
 This model resulted in a resubstitution Brier score of 
0.123 and AUC of 72.8%. Internally validated 0.632+ 
bootstrap estimators of the Brier score and the AUC were 
calculated as 0.131 and 69.4%, respectively. We also inves-
tigated the model selection behavior across bootstrap 
samples. The average number of selected variables was 
6.04 (standard error 0.28). We note that unilateral paresis 
and memory loss were selected in all bootstrap samples, 
indicating that these are very stable predictors.
 Finally, we included transient monocular blindness 
and diplopia in an exact logistic model, together with 
unilateral paresis, headache, memory loss and blurred vi-
sion. Owing to computer memory constraints we had to 
refrain from evaluating the effects of the latter variables 
in this model. However, we obtained a TIA mimics OR of 
0.15 for transient monocular blindness (95% CI 0–0.95) 
and 0.14 for diplopia (95% CI 0–1.03), indicating that both 
features decrease the odds of TIA mimics once the other 
factors are taken into account.
 Outcome of Patients with TIA Mimics and TIA 
 The combined outcome event (stroke, TIA, MI or 
death within 90 days) occurred in 36 TIA patients (14.5%) 
and in none of the patients with TIA mimics ( table 5 ). 
These events were 13 strokes (5.2%), 20 recurrent TIAs 
(8.1%) and 3 MIs (1.2%). No patient died during the fol-
low-up period. One of the strokes occurred within 30 
days of carotid stenting. 
 Discussion 
 This prospective study yielded the following main re-
sults: (1) about 1 out of 5 patients with a tentative diagno-
sis of TIA made by an EMD physician had a TIA mimic 
rather than a true TIA; (2) paresis suggested TIA; (3) du-
ration of symptoms, blood pressure values, language or 
speech abnormalities and sensory symptoms did not pre-
dict either entity, and (4) at 3 months, stroke, recurrent 
TIA, MI or death were absent in patients with TIA mim-
ics but occurred in 14.5% of the TIA patients.
 The proportion of patients with TIA mimics (18.2%, 
95% CI 14.0–23.0%) is in the range of rates reported in 
studies with a similar setting (10, 24, 38 and 48.5%)  [14–
17] . Some of these studies reported on clinical differences 
Table 2. C auses of TIA mimics
Diagnosis of TIA mimics (n = 55) n
Epileptic seizures 26 (43.7)
Migraine 13 (23.6)
Psychogenic hyperventilation 4 (7.3)
Hypertensive encephalopathy 2 (3.6)
Transient global amnesia 2 (3.6)
Sepsis 2 (3.6)
Hypoglycaemia 1 (1.8)
Benign paroxysmal vertigo 1 (1.8)
Cerebral venous thrombosis 1 (1.8)
Neoplasm of the brain 1 (1.8)
Subarachnoid bleeding 1 (1.8)
Peripheral nerve lesion 1 (1.8)
V alues in parentheses represent percentages. Diagnostic crite-
ria for epileptic seizures according to the definitions proposed by 
the International League Against Epilepsy and the International 
Bureau for Epilepsy [39]. Diagnostic criteria for migraine with 
aura were those defined by the International Headache Society 
[40].
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Table 3. P atient baseline characteristics and unadjusted ORs for factors associated with TIA mimics
Covariate All patients
(n = 303)
TIA mimics
(n = 55; 18.2%)
TIA
(n = 248; 81.8%)
OR 95% CI
Age, years 71 (61.0–79.0) 66 (56.0–76.5) 72 (62.0–79.0) 0.901 0.81–1.00
Blood pressure
Systolic, mm Hg
Diastolic, mm Hg
156.0 (139.0–175.0)
85 (77.0–96.0)
157.0 (139.5–170.5)
85.0 (78.5–97.5)
155.5 (139.0–175.8)
85.5 (77.0–96.0)
0.992
1.012
0.94–1.04
0.92–1.10
Duration of symptoms, min 30.0 (10.0–180.0) 60.0 (15–200) 30.0 (10.0–180.0) 1.003 0.99–1.01
Clinical symptoms
Memory loss
Unilateral paresis
Blurred vision
Headache
Dysarthria
Unilateral sensory loss
Aphasia
Vertigo
Hemianopia 
15 (5.0)
161 (53.1)
25 (8.2)
15 (5.0)
58 (19.1)
105 (34.6)
65 (21.4)
45 (14.8)
11 (3.6)
10 (18.2)
16 (29.1)
12 (21.8)
8 (14.6)
7 (12.7)
20 (36.4)
12 (21.8)
8 (14.6)
2 (3.6)
5 (2.0)
145 (58.5)
13 (5.2)
7 (2.8)
51 (20.6)
85 (34.3)
53 (21.4 )
37 (14.9)
9 (3.6)
10.80
0.29
5.04
5.86
0.56
1.10
1.03
0.97
1.00
3.66–36.07
0.15–0.54
2.14–11.87
2.01–17.47
0.22–1.25
0.59–2.00
0.49–2.03
0.40–2.13
0.15–4.03
Transient ocular blindness 15 (5.0) 0 (0.0) 15 (6.0) 0.204 0.00–1.23
Diplopia 12 (4.0) 0 (0.0) 12 (4.8) 0.264 0.00–1.60
V alues represent medians (interquartile ranges) or numbers (percentages). 
1 Per 5 years. 2 Per 5 mm Hg. 3 Per 10 min. 4 Median unbiased estimator [27].
Table 4. R esults of stepwise linear logistic regression for the odds of TIA mimics, based on 301 patients without 
missing values
Covariate OR 95% CI
Memory loss 9.17 2.89–32.50
Unilateral paresis 0.35 0.17–0.68
Headache 3.71 1.07–12.78
Blurred vision 2.48 0.90–6.59
Table 5. V ascular outcome events
All patients
(n = 303)
TIA mimics
(n = 55; 18.2%)
TIA
(n = 248; 81.8%)
Outcome events, n
Cerebrovascular events
Ischemic stroke
Recurrent TIA
Death
MI
36 (11.9)
13 (4.3)
20 (6.6)
0
3 (1)
0
0
0
0
0
36 (14.5)
13 (5.2)
20 (8.1)
0
3 (1.2)
O utcome events were assessed at 90 days. Values in parentheses represent percentages.
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between patients with TIA mimics and true TIA, such as 
a higher ABCD score or differences in the occurrence of 
hemiparesis, speech disturbances, a gradual symptom 
onset and prior history of unexplained transient neuro-
logic attack  [15–17, 33] , but none of them provided a com-
prehensive analysis of the distribution of clinical signs 
within both groups.
 In our study population, patients with transient uni-
lateral paresis were more likely to have a final diagnosis 
of TIA. This finding mirrored a similar observation from 
a study comparing stroke versus stroke mimics  [12] . 
Weakness as a TIA symptom is a known predictor of con-
secutive stroke and represents an important element in 
clinical scores used to predict stroke risk  [7, 23] . Some of 
the predictive capability of the ABCD2 or ABCD score 
may be explained by the fact that patients with low scores 
may in truth have a TIA mimic rather than a true TIA 
 [15–17] . However, these scores were not developed to dis-
tinguish TIA mimics from TIA and therefore cannot be 
recommended to be used as a diagnostic instrument in 
this context  [16] .
 Memory loss, headache and blurred vision were sig-
nificantly more frequent in patients with TIA mimics 
than in those with true TIA. These symptoms are com-
mon in patients with epileptic seizures and migraine, 
which represented the most frequent disorders mimick-
ing TIA in our population.
 Blood pressure values on admission did not differ be-
tween patients with TIA mimics and TIA patients. This 
appears counterintuitive, as stroke patients had signifi-
cantly higher blood pressure values than patients with 
stroke mimics  [12, 17] . Hypertensive encephalopathy 
among patients with TIA mimics might be a theoretical 
explanation for this finding. However, in our study only 2 
patients with TIA mimics were diagnosed with this dis-
order. A more likely explanation is that unlike stroke, TIA 
does not result in a sustained blood pressure response.
 Speech and language disturbances did not differ be-
tween patients with TIA and TIA mimics in our study. 
This finding contrasts with acute stroke assessment tools; 
speech is a component of the Face Arm Speech Test  [34] , 
the Cincinnati Prehospital Stroke Scale  [35] and the Rec-
ognition of Stroke in the Emergency Room scale  [36] . As 
a possible explanation, unlike persistent aphasia, transient 
aphasia may be caused by transient cerebral ischemia but 
also by an epileptic seizure or a migraine attack  [13, 37] .
 In the present study, approximately 1 out of 7 TIA pa-
tients had a subsequent vascular event within 3 months 
after the TIA. Recurrent TIAs (8.1%) were more frequent 
than strokes (5.2%). MIs were rare (1.2%). Consistent with 
previous research, most of these events occurred in the 
first 30 days  [38] . No vascular outcome events occurred 
among patients with TIA mimics. This finding might 
also be considered an ‘ad posterior validation’ of the di-
agnosis mimics. Our study therefore demonstrated that 
differentiating between disorders mimicking TIA and 
true TIAs is also relevant with regard to the short-term 
risk of vascular events; differences in management and 
resource allocation between patients with true TIA and 
TIA mimics are therefore justified.
 We are aware of the following limitations. Firstly, the 
relatively small number of patients with TIA mimics 
forced us to restrict the numerous possible clinical symp-
toms to 15 key features. Secondly, the interobserver reli-
ability of the diagnosis of TIA is low  [20, 21] . Thirdly, in 
order to minimize the risk of misclassification, we used 
an experts’ consensus approach as done in previous stud-
ies on stroke mimics  [12, 13] . Fourthly, we did not con-
sider whether the onset of symptoms was abrupt or devel-
oped within seconds. Fifthly, we did not include the re-
sults of diagnostic investigations such as neuroimaging 
or EEG findings in this comparative analysis, as we fo-
cused on clinical differences. A refined analysis of the 
clinical significance of MRI in patients with suspected 
TIA is in progress. 
 In general, our data will be helpful for the development 
of a diagnostic tool to distinguish between TIA and TIA 
mimics. Our study presents a valid first approach for the 
selection of features that may be indicative for distin-
guishing between the two entities. However, further re-
search is needed to build a valid prediction model. The 
added value of transient monocular blindness and diplo-
pia needs to be evaluated in more detail, whereas the se-
lection of important variables and selection of the func-
tional form for continuous variables remain key aspects 
of model building. Investigation of the stability of a mod-
el and internal validation to assess its predictive perfor-
mance are also required. Ultimately, a model will have to 
be externally validated and tested for clinical implica-
tions.
 In conclusion, among patients with suspected TIA in 
the EMD, 1 out of 5 patients had a TIA mimic. Patients 
with TIA mimics were approximately 6 years younger 
than those with true TIA. Paresis suggested TIA, while 
duration of the symptoms, blood pressure values, lan-
guage or speech abnormalities and sensory symptoms 
were not shown to distinguish between the two entities. 
The absence of vascular events or deaths within 3 months 
among patients with TIA mimics indicated a favorable 
short-term prognosis.
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